课题基金 / 基金详情

Core--Molecular detection

Core--Molecular detection
核心--分子检测
批准号:
7090250
负责人:
Gail V. W. Johnson
金额:
$20.36万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-01 至 2010-05-31

项目摘要

项目成果

Gail V. W. Johnson的其他基金

相似基金

相关文献

中文摘要
翻译
描述:分子检测核心(MDC)旨在满足UAB中未满足的需求 神经科学社区的灵敏,自动免疫组织化学(IHC)和原位杂交(ISH)检测。该设施的核心将是一个Ventana Discovery 1系统,能够完全自动化IHC和ISH应用。该系统与训练有素的技术支持人员相结合,将为新手和有经验的IHC/ISH研究者产生非paraheled高通量,可重复的分子定位结果。Discovery系统是唯一能够进行ISH和多标记定位程序的商用自动检测仪器,MDC将是UAB第一个具有这些功能的任何类型的设施。MDC将提供常规和超灵敏的酪胺信号放大-Plus(TSA -Plus)检测程序,该程序由Kevin A.罗斯,核心主任,与珀金埃尔默生命科学的科学家合作。Roth博士的实验室最近开发的一种新的灵敏和光稳定的免疫荧光检测方法,使用TSA和量子点标记相结合,也将可用。MDC还将提供显色和荧光检测选项,并执行多标记IHC和ISH程序。对于没有经验的用户,MDC人员将协助研究人员确定最佳固定条件,组织处理技术和实验设计,用于检测感兴趣的神经系统相关分子。为 MDC将提供一致、高质量的标记样本,并协助开发和实施新的检测程序。MDC将维护一个网站,在该网站上可以访问协议、共享图像以及向其他核心用户提问。每年将主办一次小型研讨会,让研究人员向其他核心用户介绍他们的研究结果,并帮助促进合作研究工作。该核心的总体目标是为NINDS支持的研究人员和其他UAB神经科学研究人员提供最先进的分子检测技术,以便更有效地 有效实现研究目标。我们希望MDC成为现有UAB校园设施之间的重要桥梁。因此,我们将从几个组织处理核心实验室中的任何一个接收标本输入,并生产可以在几个成像设施中的任何一个(标准和共聚焦显微镜设施都是现成的)进行可视化的IHC/ISH标记载玻片。或者,研究者可以提交在其自己的实验室或使用MDC相关组织处理设备制备的细胞和/或组织切片进行IHC/ISH标记,随后使用MDC或其自己的实验室提供的显微镜进行可视化。这种实验的高度灵活性将允许每个研究者“定制”他们的MDC使用,以最好地满足他们的个人需求。
英文摘要
DESCRIPTION: The Molecular Detection Core (MDC) is designed to fill an unmet need in the UAB neuroscience community for sensitive, automated immunohistochemistry (IHC) and in situ hybridization (ISH) detection. The centerpiece of the facility will be a Ventana Discovery1 System capable of fully automated IHC and ISH applications. This system, combined with well-trained technical support staff, will produce unparaheled high-throughput, reproducible, molecular localization results for both novice and experienced IHC/ISH investigators. The Discovery System is the only commercially-available automated detection instrument capable of ISH and multi-label localization procedures and the MDC will be the first facility of any type at UAB with these capabilities. The MDC will offer both conventional and ultrasensitive Tyramide Signal Amplification-Plus (TSA -Plus) detection procedures developed by Dr. Kevin A. Roth, core director, in collaboration with scientists at Perkin-Elmer Life Sciences. A novel procedure for sensitive and photostable immunofluorescence detection using combined TSA and quantum dot labeling, recently developed by Dr. Roth's laboratory, will also be available. The MDC will also offer both chromogenic and fluorescent detection options as well as perform multi-labeling IHC and ISH procedures. For inexperienced users, MDC personnel will assist investigators in determining optimal fixation conditions, tissue processing techniques, and experimental designs for detection of nervous system-associated molecules of interest. For experienced IHC/ISH investigators, the MDC will provide consistent, high quality labeled samples and assist in the development and implementation of novel detection procedures. The MDC will maintain a website where protocols can be accessed, images shared, and questions asked of other core users. An annual mini-symposium will be sponsored for investigators to present their results to other core users and to help facilitate collaborative research efforts. The overall goal of this core is to provide NINDS supported investigators, and other UAB neuroscience investigators, with state of the art molecular detection techniques so as to more effectively and efficiently achieve their research objectives. We expect the MDC to be an important bridge between pre-existing UAB campus facilities. Thus, we will receive specimen input from any of several tissue processing core laboratories and produce IHC/ISH labeled slides that can be visualized at any of several imaging facilities (both standard and confocal microscopy facilities are readily available). Alternatively, investigators may submit cell and/or tissue sections prepared in their own laboratory or with MDC-associated tissue processing equipment for IHC/ISH labeling with subsequent visualization performed using microscopes available in the MDC or in their own laboratories. This large degree of experimental flexibility will permit each investigator to "customize" their MDC usage to best meet their individual needs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial dysfunction and tau pathology in Alzheimer's disease
  • 批准号:
    10805120
  • 项目类别:
  • 资助金额:
    $42.35万
  • 财政年份:
    2023
  • 负责人:
    Gail V. W. Johnson
  • 依托单位:
Mechanisms of Transglutaminase 2 (TG2)-Mediated Gene Expression in Astrocyte
  • 批准号:
    10293984
  • 项目类别:
  • 资助金额:
    $42.35万
  • 财政年份:
    2021
  • 负责人:
    Gail V. W. Johnson
  • 依托单位:
BAG3 regulates Rab35 and the ESCRT/endolysosome pathway
  • 批准号:
    10269305
  • 项目类别:
  • 资助金额:
    $43.63万
  • 财政年份:
    2021
  • 负责人:
    Gail V. W. Johnson
  • 依托单位:
BAG3 regulates Rab35 and the ESCRT/endolysosome pathway
  • 批准号:
    10461933
  • 项目类别:
  • 资助金额:
    $43.63万
  • 财政年份:
    2021
  • 负责人:
    Gail V. W. Johnson
  • 依托单位:
海外基金